[AACR] T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study |
|
This post will be closed automatically in 2026-08-27 15:48
Reward30points
|
| |
post
reply
points
1400
25
A Randomized, Nivolumab-Controlled, Phase II Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
50
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation每Mediated TXNRD1 Stabilization to Suppress Ferroptosis
20
Lipid Nanoparticle每Encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36污 plus Durvalumab Induces an Immunostimulatory Effect within the Tumor Microenvironment in Patients with Advanced Solid Tumors
30
Abstract 955: LY3200882, a novel, highly selective TGF汕RI small molecule inhibitor
